PATENT CLAIM ANALYSIS

Application Number: 16189461
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["540", "200000"]

Abstract:
[Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

Claim (Index 17):
The method of  claim 14 , wherein pathogenic bacteria causing the respiratory infection are one or more types of bacteria selected from the group consisting of bacteria belonging to  Staphylococcus  sp., bacteria belonging to  Streptococcus  sp.,  Moraxella catarrhalis , bacteria belonging to  Klebsiella  sp.,  Haemophilus influenzae , and  Escherichia coli.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.33333
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14352141', '14741713', '10569062', '15578764', '15578758']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7810621212446
- 35 USC 102 Novelty (BERT): 0.5458102183031669
- Combined Prediction Score: 0.7575369309504566
- Mean Citation Score: 355.84123
- Max Citation Score: 430.11282
- Similarity Product: 251.4593244635582

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test